Article
TSPAN12 is overexpressed in NSCLC via p53 inhibition and promotes NSCLC cell growth in…
OncoTargets and Therapy · 2018 · Hu Z, Hou D, Wang X, You Z, Cao X
Key facts
| Title | TSPAN12 is overexpressed in NSCLC via p53 inhibition and promotes NSCLC cell growth in vitro and in vivo |
|---|---|
| First author | Hu Z, Hou D, Wang X, You Z, Cao X |
| Journal | OncoTargets and Therapy |
| Published | Mar 1, 2018 |
| DOI | 10.2147/OTT.S155620 |
| Product codes mentioned | GIA |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1